http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-845034-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcbc1de8801460caf80ad76627ae20b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-20
filingDate 1957-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71c17c605c2f048ef120ab7e8668ec16
publicationDate 1960-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-845034-A
titleOfInvention Improvements in or relating to the production of heterocyclic compounds
abstract The invention comprises a process for the preparation of indole derivatives of the general formula: <FORM:0845034/IV(b)/1> (wherein R is an alkyl or aralkyl group, R1 and R2 are alkyl groups containing at most 4 carbon atoms and R3 is a hydrogen atom or an alkyl group containing at most 4 carbon atoms) in which a di-lower alkyl a -acylaminomalonate is added to acrylic aldehyde to produce a 3:3-di-(carbalkoxy) - 3 - acylaminobutyraldehyde, this is condensed with a 4-alkoxy- or 4-aralkoxy-phenyhydrazine and the 4-alkyl- or 4-aralkyl-phenylhydrazone is cyclized with elimination of ammonia. The addition process is advantageously effected by heating equimolecular proportions of the reactants at less than 45 DEG C., the formation of the phenylhydrazone is preferably carried out at an elevated temperature using equimolecular proportions of the reactants and the final cyclization is desirably effected with sulphuric acid, boron trifluoride or zinc chloride, and most desirably with excess sulphuric acid at an elevated temperature. The intermediate products in the above process need not be isolated, and all the reactions may be carried out in a nuclearly-chlorinated aromatic hydrocarbon, such as chlorobenzene or o-dichlorobenzene or a mixture thereof. The above process may be combined with a process for the preparation of 5-hydroxytryptophan, by converting the indole derivative of the above general formula into 5-hydroxytryptophan by known methods of hydrolysis and decarboxylation of substituted malonic esters, followed by hydrolysis (where necessary) of the acylamino group and reductive fission of the group R by known methods. If R3 is a hydrogen atom the formylamino group is hydrolysed simultaneously with the ester groups R1 and R2. An example describes the preparation of ethyl a -acetylamino-a -carbethoxy-,b -(5-benzyloxyindolyl-3) -propionate and the conversion of this to 5-hydroxy-tryptophan via a -acetylamino-a -carboxy - b - (5-benzyloxy-indolyl-3)-propionic acid, a -acetylamino - b (5-benzyloxy-indolyl-3)-propionic acid and 5-benzyloxytryptophan. 4-Alkoxy- and 4-aralkoxy-phenylhydrazines are prepared by diazotizing the appropriately substituted anilines and reducing the resultant diazo compounds. The preparation of 4-benzyloxyphenylhydrazine hydrochloride is described. In the Provisional Specification this compound is prepared by diazotizing 4-benzyloxyaniline hydrochloride, reacting the product with sodium meta bisulphite, sodium acetate and sodium hydroxide to form sodium 4-benzyloxyphenyl diazonium sulphonate, reducing this with zinc and acetic acid to the hydrazosulphonate and hydrolysing this with ethanol and hydrochloric acid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106478485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106478485-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4316847-A
priorityDate 1957-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160426389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450136125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453918403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416138100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449472542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21696466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2053708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450351224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452064691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451615822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406948316

Total number of triples: 59.